RxDoctor Payments Data

Stephen Lile

Optometrist · Leawood, KSNPI 1114053055

Payments from drug & device makers

$2,332in general payments, 2019–2025

Across 57 payments — averaging $40.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Vision Care, Inc.$691
  • Bausch & Lomb Americas Inc.$279
  • Alcon$269
  • Coopervision Inc.$269
  • Sun Pharmaceutical Industries Inc.$201
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$199
  • plus $425 from 6 others
$10in research payments, 2019–2025

Across 1 payment — averaging $10.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Rxsight Inc$10

What the payments were for

  • Food & beverage$2,332100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,332 in reported general payments places this provider in the 80th percentile of 567 optometrist providers in Kansas.

See all optometrist providers in Kansas

Medicare billing

Part B allowed, 2024
$29,941
Medicare patients
252
Services billed
277

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate17$871
Latanoprost72$711
Dorzolamide Hcl11$275

Paid to pharmacies, not to this prescriber.

Other optometrist in Leawood

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →